The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Mechanisms of Action of Adjuvants
Open accessAbstract
Adjuvants are used in many vaccines, but their mechanisms of action are not fully understood. Studies from the past decade on adjuvant mechanisms are slowly revealing the secrets of adjuvant activity. In this review, we have summarized the recent progress in our understanding of the mechanisms of action of adjuvants. Adjuvants may act by a combination of various mechanisms including formation of depot, induction of cytokines and chemokines, recruitment of immune cells, enhancement of antigen uptake and presentation, and promoting antigen transport to draining lymph nodes. It appears that adjuvants activate innate immune responses to create a local immuno-competent environment at the injection site. Depending on the type of innate responses activated, adjuvants can alter the quality and quantity of adaptive immune responses. Understanding the mechanisms of action of adjuvants will provide critical information on how innate immunity influences the development of adaptive immunity, help in rational design of vaccines against various diseases, and can inform on adjuvant safety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
Approaching the Asymptote? Evolution and Revolution in Immunology
Janeway, C. A. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,252
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658 · cited 1×
“Further, blocking ROS using chemical scavengers abolished NLRP3 activation in response to MSU suggesting a link between NLRP3 activation and ROS generation (Dostert et al., 2008).”
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection
Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D. J., & Sansonetti, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200651200 · Cited by 2,408
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan
Girardin, S. E., Boneca, I. G., Carneiro, L. A. M., Antignac, A., Jéhanno, M., Viala, J., Tedin, K., Taha, M.-K., Labigne, A., Zäthringer, U., et al. (2003) · Science · doi:10.1126/science.1084677 · Cited by 1,577
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542
Klinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J., & Krieg, A. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2879 · Cited by 1,477
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445 · cited 3×
“Extracellular ATP triggered stimulation of purinergic P2X7 receptor, resulting in activation of cation channel for K+ efflux and opening of pannexin-1 pore for entry of danger signals generated by alum, activate NLRP3 and subsequently caspase-1 (Solle et al., 2001; Petrilli et al., 2007).”
BackgroundChamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., Kawasaki, A., Fukase, K., Kusumoto, S., et al. (2003) · Nature Immunology · doi:10.1038/ni945 · Cited by 1,323
The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus
Zhao, Y., Yang, J., Shi, J., Gong, Y.-N., Lu, Q., Xu, H., Liu, L., & Shao, F. (2011) · Nature · doi:10.1038/nature10510 · Cited by 1,270
LeibundGut-Landmann, S., Groß, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E., Tybulewicz, V., Brown, G. D., Ruland, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1460 · Cited by 1,191
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J., Perregaux, D. G., Stam, E., Petrushova, N., Koller, B. H., Griffiths, R. J., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 930
The interface between innate and adaptive immunity
Hoebe, K., Janssen, E., & Beutler, B. (2004) · Nature Immunology · doi:10.1038/ni1004-971 · Cited by 916
Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity
Kofoed, E. M., & Vance, R. E. (2011) · Nature · doi:10.1038/nature10394 · Cited by 891
Towards an understanding of the adjuvant action of aluminium
Marrack, P., McKee, A. S., & Munks, M. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2510 · Cited by 887
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo.
De Smedt, T., Pajak, B., Muraille, E., Lespagnard, L., Heinen, E., De Baetselier, P., Urbain, J., Leo, O., & Moser, M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1413 · Cited by 762
Didierlaurent, A. M., Morel, S., Lockman, L., Giannini, S. L., Bisteau, M., Carlsen, H., Kielland, A., Vosters, O., Vanderheyde, N., Schiavetti, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901474 · Cited by 758
Fujii, S.-I., Shimizu, K., Smith, C., Bonifaz, L., & Steinman, R. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030324 · Cited by 711
Adjuvants—a classification and review of their modes of action
Cox, J. C., & Coulter, A. R. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00183-1 · Cited by 682
Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP3
Li, H., Willingham, S. B., Ting, J. P.-Y., & Re, F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.17 · Cited by 675
In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
Deres, K., Schild, H., Wiesmüller, K.-H., Jung, G., & Rammensee, H.-G. (1989) · Nature · doi:10.1038/342561a0 · Cited by 631
The perfect mix: recent progress in adjuvant research
Guy, B. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1681 · Cited by 620
Kool, M., Pétrilli, V., De Smedt, T., Rolaz, A., Hammad, H., van Nimwegen, M., Bergen, I. M., Castillo, R., Lambrecht, B. N., & Tschopp, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3755 · Cited by 611
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
Gavin, A. L., Hoebe, K., Duong, B., Ota, T., Martin, C., Beutler, B., & Nemazee, D. (2006) · Science · doi:10.1126/science.1135299 · Cited by 581
Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
Casella, C. R., & Mitchell, T. C. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8228-6 · Cited by 560
Targeting the innate immune response with improved vaccine adjuvants
Pashine, A., Valiante, N. M., & Ulmer, J. B. (2005) · Nature Medicine · doi:10.1038/nm1210 · Cited by 555
van Beelen, A. J., Zelinkova, Z., Taanman-Kueter, E. W., Muller, F. J., Hommes, D. W., Zaat, S. A. J., Kapsenberg, M. L., & de Jong, E. C. (2007) · Immunity · doi:10.1016/j.immuni.2007.08.013 · Cited by 518
Molecular and cellular signatures of human vaccine adjuvants
Mosca, F., Tritto, E., Muzzi, A., Monaci, E., Bagnoli, F., Iavarone, C., O'Hagan, D., Rappuoli, R., & De Gregorio, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804699105 · Cited by 492
Morel, S., Didierlaurent, A., Bourguignon, P., Delhaye, S., Baras, B., Jacob, V., Planty, C., Elouahabi, A., Harvengt, P., & Carlsen, H. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.011 · Cited by 476
Franchi, L., & Núñez, G. (2008) · European Journal of Immunology · doi:10.1002/eji.200838549 · Cited by 450
Calabro, S., Tortoli, M., Baudner, B. C., Pacitto, A., Cortese, M., O’Hagan, D. T., De Gregorio, E., Seubert, A., & Wack, A. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.090 · Cited by 433
Seubert, A., Monaci, E., Pizza, M., O’Hagan, D. T., & Wack, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5402 · Cited by 430
Coyle, A. J., & Gutierrez-Ramos, J.-C. (2001) · Nature Immunology · doi:10.1038/85251 · Cited by 413
Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity
Flach, T. L., Ng, G., Hari, A., Desrosiers, M. D., Zhang, P., Ward, S. M., Seamone, M. E., Vilaysane, A., Mucsi, A. D., Fong, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2306 · Cited by 405
McKee, A. S., Munks, M. W., MacLeod, M. K. L., Fleenor, C. J., Van Rooijen, N., Kappler, J. W., & Marrack, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900164 · Cited by 392
Hsu, L.-C., Ali, S. R., McGillivray, S., Tseng, P.-H., Mariathasan, S., Humke, E. W., Eckmann, L., Powell, J. J., Nizet, V., Dixit, V. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802726105 · Cited by 387
Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential
Stanley, M. A. (2002) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2002.01151.x · Cited by 377
Kerkmann, M., Rothenfusser, S., Hornung, V., Towarowski, A., Wagner, M., Sarris, A., Giese, T., Endres, S., & Hartmann, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4465 · Cited by 352
Tolerance, Danger and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.991 · Cited by 335
Aluminum Hydroxide Adjuvants Activate Caspase-1 and Induce IL-1β and IL-18 Release
Li, H., Nookala, S., & Re, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5271 · Cited by 332
Fritz, J. H., Le Bourhis, L., Sellge, G., Magalhaes, J. G., Fsihi, H., Kufer, T. A., Collins, C., Viala, J., Ferrero, R. L., Girardin, S. E., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.009 · Cited by 331
Immunological concepts of vaccine adjuvant activity
Schijns, V. E. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00120-5 · Cited by 330
Werninghaus, K., Babiak, A., Groß, O., Hölscher, C., Dietrich, H., Agger, E. M., Mages, J., Mocsai, A., Schoenen, H., Finger, K., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081445 · Cited by 315
Flagellin Promotes Myeloid Differentiation Factor 88-Dependent Development of Th2-Type Response
Didierlaurent, A., Ferrero, I., Otten, L. A., Dubois, B., Reinhardt, M., Carlsen, H., Blomhoff, R., Akira, S., Kraehenbuhl, J.-P., & Sirard, J.-C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6922 · Cited by 310
MF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines
Ott, G., Barchfeld, G. L., Chernoff, D., Radhakrishnan, R., van Hoogevest, P., & Van Nest, G. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_10 · Cited by 298
Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro
Morefield, G. L., Sokolovska, A., Jiang, D., HogenEsch, H., Robinson, J. P., & Hem, S. L. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.07.050 · Cited by 293
Grun, J. L., & Maurer, P. H. (1989) · Cellular Immunology · doi:10.1016/0008-8749(89)90011-7 · Cited by 281
Wagner, T. L., Ahonen, C. L., Couture, A. M., Gibson, S. J., Miller, R. L., Smith, R. M., Reiter, M. J., Vasilakos, J. P., & Tomai, M. A. (1999) · Cellular Immunology · doi:10.1006/cimm.1998.1406 · Cited by 258
Promotion of B Cell Immune Responses via an Alum-Induced Myeloid Cell Population
Jordan, M. B., Mills, D. M., Kappler, J., Marrack, P., & Cambier, J. C. (2004) · Science · doi:10.1126/science.1089926 · Cited by 248
Antigen depot is not required for alum adjuvanticity
Hutchison, S., Benson, R. A., Gibson, V. B., Pollock, A. H., Garside, P., & Brewer, J. M. (2012) · The FASEB Journal · doi:10.1096/fj.11-184556 · Cited by 244
Alum adjuvanticity: Unraveling a century old mystery
De Gregorio, E., Tritto, E., & Rappuoli, R. (2008) · European Journal of Immunology · doi:10.1002/eji.200838648 · Cited by 232
Schijns, V. E., & Lavelle, E. C. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.21 · Cited by 211
Recent advances in veterinary vaccine adjuvants
Singh, M., & O'Hagan, D. T. (2003) · International Journal for Parasitology · doi:10.1016/s0020-7519(03)00053-5 · Cited by 207
Sokolovska, A., Hem, S. L., & HogenEsch, H. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.03.045 · Cited by 201
Henriksen-Lacey, M., Bramwell, V. W., Christensen, D., Agger, E.-M., Andersen, P., & Perrie, Y. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.022 · Cited by 196
Seubert, A., Calabro, S., Santini, L., Galli, B., Genovese, A., Valentini, S., Aprea, S., Colaprico, A., D'Oro, U., Giuliani, M. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107941108 · Cited by 191
Liposomal delivery of antigen to human dendritic cells
Copland, M. J., Baird, M. A., Rades, T., McKenzie, J. L., Becker, B., Reck, F., Tyler, P. C., & Davies, N. M. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00536-4 · Cited by 184
Mannhalter, J. W., Neychev, H., Zlabinger, G. J., Ahmad, R., & Eibl, M. M. (1985) · PubMed Central · Cited by 183
The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells
De Becker, G., Moulin, V., Pajak, B., Bruck, C., Francotte, M., Thiriart, C., Urbain, J., & Moser, M. (2000) · International Immunology · doi:10.1093/intimm/12.6.807 · Cited by 182
T cell–intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii
Shaw, M. H., Reimer, T., Sánchez-Valdepeñas, C., Warner, N., Kim, Y.-G., Fresno, M., & Nuñez, G. (2009) · Nature Immunology · doi:10.1038/ni.1816 · Cited by 179
Yan, W., Chen, W., & Huang, L. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.04.009 · Cited by 177
Rimaniol, A., Gras, G. S., Verdier, F., Capel, F., Grigoriev, V. B., Porcheray, F., Sauzeat, E., Fournier, J. G., Clayette, P., Siegrist, C., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.061 · Cited by 157
Glück, R., Mischler, R., Brantschen, S., et al. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116141 · Cited by 156
The mode of action of mineral-oil emulsion adjuvants on antibody production in mice.
Herbert, W. J. (1968) · PubMed · Cited by 155
Sun, H., Pollock, K. G. J., & Brewer, J. M. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00531-5 · Cited by 155
Self-Adjuvanting Lipopeptide Vaccines
Moyle, P., & Toth, I. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783503249 · Cited by 155
Differential Requirements for NAIP5 in Activation of the NLRC4 Inflammasome
Lightfield, K. L., Persson, J., Trinidad, N. J., Brubaker, S. W., Kofoed, E. M., Sauer, J., Dunipace, E. A., Warren, S. E., Miao, E. A., & Vance, R. E. (2011) · Infection and Immunity · doi:10.1128/iai.01187-10 · Cited by 153
Ghimire, T. R., Benson, R. A., Garside, P., & Brewer, J. M. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.06.002 · Cited by 149
Virosome-mediated delivery of protein antigens to dendritic cells
Bungener, L. B., Serre, K., Bijl, L., Leserman, L., Wilschut, J., Daemen, T., & Machy, P. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00103-2 · Cited by 147
Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis
Dupuis, M., Denis-Mize, K. S., LaBarbara, A., Peters, W., Charo, I. F., McDonald, D. M., & Ott, G. S. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<2910::aid-immu2910>3.0.co;2-3 · Cited by 145
Efficiency of peptides and lipopeptides for in vivo priming of virus‐specific cytotoxic T cells
Schild, H., Deres, K., Wiesmüller, K., Jung, G., & Rammensee, H. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211102 · Cited by 140
Goto, N., Kato, H., Maeyama, J., Shibano, M., Saito, T., Yamaguchi, J., & Yoshihara, S. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00054-6 · Cited by 136
Vesicle Size Influences the Trafficking, Processing, and Presentation of Antigens in Lipid Vesicles
Brewer, J. M., Pollock, K. G. J., Tetley, L., & Russell, D. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6143 · Cited by 135
Pivotal Advance: Eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production
Wang, H., & Weller, P. F. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607392 · Cited by 124
Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice
Dupuis, M. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00263-7 · Cited by 123
Ellebedy, A. H., Lupfer, C. R., Ghoneim, H. E., DeBeauchamp, J., Kanneganti, T., & Webby, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012455108 · Cited by 119
Korsholm, K. S., Petersen, R. V., Agger, E. M., & Andersen, P. L. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03164.x · Cited by 111
Guéry, J., Ria, F., & Adorini, L. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.751 · Cited by 110
Iyer, S., HogenEsch, H., & Hem, S. L. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00556-x · Cited by 104
DiC14‐amidine cationic liposomes stimulate myeloid dendritic cells through Toll‐like receptor 4
Tanaka, T., Legat, A., Adam, E., Steuve, J., Gatot, J., Vandenbranden, M., Ulianov, L., Lonez, C., Ruysschaert, J., Muraille, É., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200737998 · Cited by 98
Em, C., & Bosco, G. (2014) · Cited by 98
Immunostimulatory DNA Prepriming: A Novel Approach for Prolonged Th1-Biased Immunity
Kobayashi, H., Horner, A. A., Takabayashi, K., Nguyen, M.-D., Huang, E., Cinman, N., & Raz, E. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1572 · Cited by 94
Wang, Y., Cella, M., Gilfillan, S., & Colonna, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903201 · Cited by 93
Histopathological Studies of Reactions in Mice Injected with Aluminum‐Adsorbed Tetanus Toxoid
Goto, N., & Akama, K. (1982) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1982.tb00261.x · Cited by 91
Improving vaccines by incorporating immunological coadjuvants
Fraser, C. K., Diener, K. R., Brown, M. P., & Hayball, J. D. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.4.559 · Cited by 83
Coexpressed RIG-I Agonist Enhances Humoral Immune Response to Influenza Virus DNA Vaccine
Luke, J., Simon, G. G., Söderholm, J., Errett, J., August, J., Gale, M., Hodgson, C. P., & Williams, J. A. (2010) · Journal of Virology · doi:10.1128/jvi.01250-10 · Cited by 83
Complement activation by aluminium and zirconium compounds.
Ramanathan, V. D., Badenoch‐Jones, P., & Turk, J. L. (1979) · PubMed · Cited by 80
McCarron, M. J., & Reen, D. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.55 · Cited by 80
Shah, J. A., Darrah, P. A., Ambrozak, D. R., Turon, T. N., Méndez, S., Kirman, J. R., Wu, C. Y., Glaichenhaus, N., & Seder, R. A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030645 · Cited by 78
Wu, J. J., Huang, D., & Tyring, S. K. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.07.002 · Cited by 76
Mechanism of Impaired NLRP3 Inflammasome Priming by Monophosphoryl Lipid A
Eaves, C. A., Franchi, L., Núñez, G., & Mitchell, T. C. (2011) · Science Signaling · doi:10.1126/scisignal.2001486 · Cited by 61
Choi, J., Kim, Y. ‐., Kim, O. Y., Kim, Y., Jeon, S. G., Roh, T. ‐., Park, J. ‐., Gho, Y. S., & Kim, Y. ‐. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02871.x · Cited by 55
Activation of adjuvant core response genes by the novel adjuvant PCEP
Awate, S., Wilson, H. L., Lai, K., Babiuk, L. A., & Mutwiri, G. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.03.026 · Cited by 53
Self-citationSerre, K., Mohr, E., Toellner, K., Cunningham, A. F., Granjeaud, S., Bird, R., & MacLennan, I. C. M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.05.010 · Cited by 48
Short- and long-term changes in gene expression mediated by the activation of TLR9
Klaschik, S., Tross, D., Shirota, H., & Klinman, D. M. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.11.014 · Cited by 46
Gram, G. J., Karlsson, I., Agger, E. M., Andersen, P. L., & Fomsgaard, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006950 · Cited by 45
Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo
Klaschik, S., Tross, D., & Klinman, D. M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008671 · Cited by 44
Bungener, L. B., Idema, J., ter Veer, W., et al. (2002) · Journal of Liposome Research · doi:10.1081/lpr-120004789 · Cited by 29
Cited by
Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals
Homayun, B., Lin, X., & Choi, H.-J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030129 · Cited by 837
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
Kyriakidis, N. C., López-Cortés, A., González, E. V., Grimaldos, A. B., & Prado, E. O. (2021) · npj Vaccines · doi:10.1038/s41541-021-00292-w · Cited by 698
Peptide Vaccine: Progress and Challenges
Li, W., Joshi, M., Singhania, S., Ramsey, K., & Murthy, A. (2014) · Vaccines · doi:10.3390/vaccines2030515 · Cited by 679
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
Didierlaurent, A. M., Laupèze, B., Di Pasquale, A., Hergli, N., Collignon, C., & Garçon, N. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1213632 · Cited by 516
Lee, Y., Jeong, M., Park, J., Jung, H., & Lee, H. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01086-x · Cited by 450
Metadata
- Authors
- Awate, S., Babiuk, L. A., & Mutwiri, G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 4
- Pages
- 114-114
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2013887826
- Cited by
- 732
- References
- 104
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.